These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22464953)

  • 21. Recent developments of functional magnetic resonance imaging research for drug development in Alzheimer's disease.
    Hampel H; Prvulovic D; Teipel SJ; Bokde AL
    Prog Neurobiol; 2011 Dec; 95(4):570-8. PubMed ID: 21777651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
    van Groen T; Kadish I
    Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.
    Bartus RT
    Exp Neurol; 2000 Jun; 163(2):495-529. PubMed ID: 10833325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selecting a mouse model of Alzheimer's disease.
    Chin J
    Methods Mol Biol; 2011; 670():169-89. PubMed ID: 20967591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.
    Fazil M; Shadab ; Baboota S; Sahni JK; Ali J
    J Drug Target; 2012 Feb; 20(2):97-113. PubMed ID: 22023651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL; Mackell J; Kaufer D
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug development status for Alzheimer's disease: present scenario.
    Misra S; Medhi B
    Neurol Sci; 2013 Jun; 34(6):831-9. PubMed ID: 23392897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of Alzheimer's disease and drug development.
    Laurijssens B; Aujard F; Rahman A
    Drug Discov Today Technol; 2013 Sep; 10(3):e319-27. PubMed ID: 24050129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Considering a new paradigm for Alzheimer's disease research.
    Langley GR
    Drug Discov Today; 2014 Aug; 19(8):1114-24. PubMed ID: 24662035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal models of human disease: challenges in enabling translation.
    McGonigle P; Ruggeri B
    Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic links between Alzheimer's disease and brain cancer: drug discovery consequences.
    Kraus JL
    ChemMedChem; 2013 May; 8(5):689-92. PubMed ID: 23444291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hunt for drugs to modify Alzheimer's disease.
    Butcher J
    Lancet Neurol; 2007 Dec; 6(12):1038-9. PubMed ID: 18031701
    [No Abstract]   [Full Text] [Related]  

  • 36. Airway disease: the use of large animal models for drug discovery.
    Van der Velden J; Snibson KJ
    Pulm Pharmacol Ther; 2011 Oct; 24(5):525-32. PubMed ID: 21356324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities.
    Van Dam D; Van Dijck A; Janssen L; De Deyn PP
    Curr Alzheimer Res; 2013 Jun; 10(5):449-68. PubMed ID: 23627705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective.
    Windisch M
    Neurodegener Dis; 2014; 13(2-3):147-50. PubMed ID: 24401335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease.
    Geerts H; Spiros A; Roberts P; Carr R
    Eur J Pharmacol; 2017 Dec; 817():38-45. PubMed ID: 28583429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing the success rate for Alzheimer's disease drug discovery and development.
    Becker RE; Greig NH
    Expert Opin Drug Discov; 2012 Apr; 7(4):367-70. PubMed ID: 22439785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.